Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

87

P943 Pseudomonas Aeruginosa Infection Induces a Lung Endothelial Cell Antiviral Gene Response: Role of a Novel tRNA Mir Residing in the Gamma Secretase Activating Protein Gene/ M.S. Gwin, Mobile, AL P944 Ex Vivo Models for Predictive Testing of Inhalable Anti-infectives in Early Pre-clinical Development/ K. Schwarz, Hannover, Germany P945 Leukemia Inhibitor Factor (LIF) Interacts With Lung Hippo Signaling During Pneumonia/ M. Perez Vazquez, Worcester, MA P946 Establishment of an Isolated Perfused Lung Model for Analysis of Local Induced Immune Response of the Immuno-modulating Agent OM-85/ H. Obernolte, Hannover, Germany P947 64-year-old: A Case of Cough and Cavities/ P. Ghai, Bridgeport, CT P948 Clinical Spectrum of Community-Acquired Pneumonia in Elderly With Comorbid Type 2 Diabetes Mellitus in a Developing Country: Exploring the Not-so-sweet Relationship/ K. Bhandari, Dharan, Nepal P949 Harvesting Septations: Loculated MSSE Empyema in a 70-Year-Old Agricultural Worker/ Z. Ali, Longview, TX P950 Drawing Attention to Signs: Diagnoses Other Than Pulmonary Tuberculosis/ F.F. Fernandes, Brasília, Brazil P951 A Case Of Pasteurella Multocida In Adult Female Pet Owner In Outpatient Clinic/ A.S. Adebola, Corvallis, OR P952 Hide and Seek: A Fatal Case of Streptococcus Constellatus Empyema and COVID-19 Infection in Elderly Patient/ K. Andrade, Forest Hills, NY P953 Microbiome Dynamics of Lower Airway Challenges With Established Microbial Concentrations/ Y. Kyeremateng, New York, NY P954 Diffuse Infection Mimicking Metastatic Colonic Cancer/ A. Medani, Rancho Mirage, CA P955 Aspiration Pneumonia Complicated by Transdiaphragmatic Empyema Necessitans/ A.M. Bischin, Lebanon, NH

P923 Persistent Ochrobactrum Anthropi Bacteremia in a Lung Transplant Recipient With Devastating COVID-19 Disease and Prolonged ECMO Cannulation: Be Aware of Rare/ D. Razia, Phoenix, AZ P924 Ochrobactrum Anthropi: A Curious Case of Pneumonia/ S. Ghosh, San Bernardino, CA P925 Clostridium Perfringens Pleural Effusion as First Presentation for Malignant Mesothelioma/ A.M. Shadid, Detroit, MI P926 Empyema Thoracis Caused by Candida Lusitaniae: A Rare but Emerging Pathogen/ S. Ashfaq, Queens, NY P927 A Case Of Non-communicative Lung And Splenic Abscesses Caused By Escherichia Coli From An Unknown Origin/ Q. Meng, Evanston, IL P928 Empyema Therapy: Is There a Difference?/ A. Elshikh, Maywood, IL P929 Double Trouble: Escherichia Coli Bilateral Empyema/ C. Tanba, Baltimore, MD P930 Pasteurella Multocida Empyema in a Patient With Oropharyngeal Cancer/ J. Sugarman, Toronto, Canada P931 MSSA Burst (MSSA Causing Refractory Bilateral Tension Pneumothorax)/ E. Karem, Huntington, WV P932 Organizing Pneumonia From Chronic Aspiration: A Lung Tumor Mimiker/ J.A.S. Cordero, Taguig, Philippines P933 A Pain In The Neck: Fusobacterium Infection During Acute COVID-19/ J. Huston, New Haven, CT P934 Bilateral Empyema From Recreational Use Of Dialysis Line/ A. Pingili, Baltimore, MD P935 Breath Taking: An Unusual Case Of Pasteurella Multocida Empyema/ L. Pitts, Winston Salem, NC P936 Persistent Pulmonary Cavitation Induced by Inverted Jejunostomy Tube/ A. Abrahamian, Toledo, OH P937 Pseudomonas Pneumonia With Pneumothorax: A Case of an Uncommon Pathogen With a Common Risk Factor/ N.C. Parker, Springfield, IL P938 True Pneumonia or Not/ A. Mckenna, Worcester, MA P939 Bleeding Bronchial Artery: To Embolize or Not?/ K. Singh, Mobile, AL P940 The Significance of Biofire Filmarray Pneumonia Panel on Pneumonia Treatment/ M.K. Ameduite, Danville, VA P941 Recurrent Pneumonia: Don’t Miss a Pulmonary Sequestration/ G.M. Gonzalez Santiago, San Juan, PR P942 Inhibiting Pyoverdine Biosynthesis Attenuates the Virulence of Pseudomonas Aeruginosa Exoenzyme Y During Infection/ A. Deweever, Mobile, AL

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A63

NTM AND BRONCHIECTASIS, STILL TOGETHER

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area I, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion

12:15-1:15 authors will be present for discussionwith assigned facilitators.

ATS 2023 • Washington, DC